Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | CASR | P41180 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29313810 | 0.88 | KDM4E (0.35) | KDM4E | |
| SCHEMBL23988563 | 0.86 | KDM4E (0.38) | KDM4ECASR | |
| SCHEMBL19660808 | 0.83 | KDM4E (0.38) | KDM4ECASRALDH1A1KMT2A | |
| SCHEMBL23837976 | 0.81 | APP (0.40) | KDM4EALDH1A1KMT2A | |
| SCHEMBL19198573 | 0.81 | KDM4E (0.36) | KDM4EALDH1A1KMT2A | |
| SCHEMBL23988618 | 0.80 | KDM4E (0.33) | KDM4E | |
| SCHEMBL21982182 | 0.80 | KDM4E (0.42) | KDM4ECASRALDH1A1 | |
| SCHEMBL18545280 | 0.79 | APP (0.38) | KDM4EALDH1A1 | |
| SCHEMBL23988566 | 0.79 | KDM4E (0.34) | KDM4E | |
| SCHEMBL23837953 | 0.78 | KDM4E (0.40) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210340404-A1 | SILANOL COMPOSITIONS AND METHODS OF USE | 3M INNOVATIVE PROPERTIES COMPANY | 2021-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210340404-A1 | SILANOL COMPOSITIONS AND METHODS OF USE | EPCAM, ITGA8, CD99 | KDM4E 985/4885CASR 4461/4885ALDH1A1 164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.